glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with Chronic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakker, SJ; de Borst, MH; Lambers Heerspink, HJ; Navis, GJ | 1 |
1 review(s) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and Chronic Kidney Diseases
| Article | Year |
|---|---|
Improving the efficacy of RAAS blockade in patients with chronic kidney disease.
Topics: Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary | 2013 |